Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002948
Basic Information
VIS ID
TVIS30002948
Fusion event
HIV-MYO1F integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr19
Cytoband
p13.2
Reference genome
GRCh37/hg19
Start
8597239/8532355 (Hg38)
End
8597239/8532355 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA19B
Target gene
MYO1F
miRNAs that regulate target gene
hsa-mir-574-5p
;
hsa-mir-6818-3p
;
hsa-mir-6873-3p
;
hsa-mir-6867-5p
;
hsa-mir-593-3p
;
hsa-mir-6895-3p
;
hsa-mir-6876-3p
;
hsa-mir-626
;
hsa-mir-6817-3p
;
hsa-mir-7110-3p
;
hsa-mir-592
;
hsa-mir-27b-3p
;
hsa-mir-27a-3p
;
hsa-mir-597-5p
;
hsa-mir-3681-3p
;
hsa-mir-216a-3p
;
hsa-mir-128-3p
;
hsa-mir-6868-3p
;
hsa-mir-6749-3p
;
hsa-mir-4685-3p
;
hsa-mir-4287
;
hsa-mir-4469
;
hsa-mir-3667-3p
;
hsa-mir-6734-3p
;
hsa-mir-5088-3p
;
hsa-mir-4667-3p
;
hsa-mir-1470
;
hsa-mir-629-3p
;
hsa-mir-6867-3p
;
hsa-mir-4448
;
hsa-mir-2276-3p
;
hsa-mir-1307-3p
;
hsa-mir-532-3p
;
hsa-mir-150-5p
;
hsa-mir-1304-3p
;
hsa-mir-1248
;
hsa-mir-1237-3p
;
hsa-mir-4726-3p
;
hsa-mir-6764-5p
;
hsa-mir-1915-3p
;
hsa-mir-6840-3p
;
hsa-mir-6890-3p
;
hsa-mir-4713-5p
;
hsa-mir-4284
;
hsa-mir-4638-5p
;
hsa-mir-2116-3p
;
hsa-mir-6741-3p
;
hsa-mir-5193
;
hsa-mir-1224-3p
;
hsa-mir-1306-5p
;
hsa-mir-498
;
hsa-mir-6071
;
hsa-mir-6828-3p
;
hsa-mir-6882-3p
;
hsa-mir-3692-5p
;
hsa-mir-93-3p
;
hsa-mir-6722-5p
;
hsa-mir-8070
;
hsa-mir-7151-3p
;
hsa-mir-5095
;
hsa-mir-6778-3p
;
hsa-mir-4707-3p
;
hsa-mir-18a-3p
;
hsa-mir-324-3p
;
hsa-mir-1913
;
hsa-mir-7107-5p
;
hsa-mir-1234-3p
;
hsa-mir-186-3p
;
hsa-mir-3934-5p
;
hsa-mir-520h
;
hsa-mir-520g-3p
;
hsa-mir-6504-3p
;
hsa-mir-3159
;
hsa-mir-552-3p
;
hsa-mir-520e
;
hsa-mir-520d-3p
;
hsa-mir-520c-3p
;
hsa-mir-520b
;
hsa-mir-520a-3p
;
hsa-mir-373-3p
;
hsa-mir-372-3p
;
hsa-mir-302e
;
hsa-mir-302d-3p
;
hsa-mir-302c-3p
;
hsa-mir-302b-3p
;
hsa-mir-302a-3p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-106b-5p
;
hsa-mir-106a-5p
;
hsa-mir-5089-5p
;
hsa-mir-6878-3p
;
hsa-mir-6744-3p
;
hsa-mir-4757-5p
;
hsa-mir-6506-5p
;
hsa-mir-619-5p
;
hsa-mir-212-5p
;
hsa-mir-512-3p
;
hsa-mir-6882-5p
;
hsa-mir-595
;
hsa-mir-4273
;
hsa-mir-4677-5p
;
hsa-mir-6739-3p
;
hsa-mir-7156-5p
Nearest miRNA
hsa-mir-1227/Upstream/142975; hsa-let-7e/Downstream/1505999;
Nearest TSS
ENST00000633603/Upstream/1871;
ENST00000598703/Downstream/7697;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/1768
,
chr19-CpG: 21/Downstream/3946
Upstream sequence
caggccCAGAAAGGAAGCTTTTGCAGAAAGCAGAGAAAAGGGTTTTGAGTTGTAAAAGTCTAGACCCAGAGGGGACTTAGAGAATGAATTACATTACAGC
Downstream sequence
AAGTCAAAGTACAAAGTCTAAGAGGAATGTCTACTCATTTGTAATAACAGCAGGTGAACAAGGTGAGGAACCTACTGGATATTAAAATACTGTAAATCTA
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate